chr19-40277925-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_001626.6(AKT2):​c.-85+7256A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0249 in 152,336 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.025 ( 85 hom., cov: 32)

Consequence

AKT2
NM_001626.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.624

Publications

4 publications found
Variant links:
Genes affected
AKT2 (HGNC:392): (AKT serine/threonine kinase 2) This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. [provided by RefSeq, Nov 2019]
AKT2 Gene-Disease associations (from GenCC):
  • hypoinsulinemic hypoglycemia and body hemihypertrophy
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • AKT2-related familial partial lipodystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • type 2 diabetes mellitus
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0249 (3797/152336) while in subpopulation NFE AF = 0.0407 (2766/68016). AF 95% confidence interval is 0.0394. There are 85 homozygotes in GnomAd4. There are 1784 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3797 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001626.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AKT2
NM_001626.6
MANE Select
c.-85+7256A>C
intron
N/ANP_001617.1P31751-1
AKT2
NM_001243027.3
c.-234+7256A>C
intron
N/ANP_001229956.1B4DG79
AKT2
NM_001243028.3
c.-141+7256A>C
intron
N/ANP_001229957.1B4DG79

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AKT2
ENST00000392038.7
TSL:1 MANE Select
c.-85+7256A>C
intron
N/AENSP00000375892.2P31751-1
AKT2
ENST00000579047.5
TSL:1
c.-141+7256A>C
intron
N/AENSP00000471369.1M0R0P9
AKT2
ENST00000391844.8
TSL:1
n.-131+7256A>C
intron
N/AENSP00000375719.4J3KT31

Frequencies

GnomAD3 genomes
AF:
0.0250
AC:
3798
AN:
152218
Hom.:
85
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00564
Gnomad AMI
AF:
0.0318
Gnomad AMR
AF:
0.0149
Gnomad ASJ
AF:
0.0358
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00372
Gnomad FIN
AF:
0.0315
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0407
Gnomad OTH
AF:
0.0263
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0249
AC:
3797
AN:
152336
Hom.:
85
Cov.:
32
AF XY:
0.0239
AC XY:
1784
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00563
AC:
234
AN:
41594
American (AMR)
AF:
0.0148
AC:
227
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0358
AC:
124
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4830
European-Finnish (FIN)
AF:
0.0315
AC:
335
AN:
10626
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0407
AC:
2766
AN:
68016
Other (OTH)
AF:
0.0260
AC:
55
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
191
382
572
763
954
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0324
Hom.:
28
Bravo
AF:
0.0238
Asia WGS
AF:
0.00318
AC:
12
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.5
DANN
Benign
0.70
PhyloP100
-0.62
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76137255; hg19: chr19-40783832; API